吉利汽車(00175.HK):2023年全年總銷量168.65萬部 超額完成全年銷量目標 2024年銷量目標190萬部
格隆匯1月1日丨吉利汽車(00175.HK)宣佈,集團於2023年12月的總銷量為150,453部汽車,較去年同期增長約3%。2023年全年的總銷量為1,686,516部,較去年同期增長約18%,超額完成集團2023年的全年銷量目標1650,000部。
董事會將集團2024年的銷量目標定為1,900,000部(包含領克品牌汽車之銷量目標),較2023年所實現的總銷量增長約13%。此外,新能源汽車的銷量目標預計較2023年所實現的總銷量增加超過66%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.